Premium
CT30
PERCUTANEOUS VALVE ACCOMPLISHMENTS AND CHALLENGES
Author(s) -
Campbell A.
Publication year - 2007
Publication title -
anz journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 70
eISSN - 1445-2197
pISSN - 1445-1433
DOI - 10.1111/j.1445-2197.2007.04115_28.x
Subject(s) - medicine , percutaneous , presentation (obstetrics) , pulmonary valve , stent , position (finance) , catheter , aortic valve , surgery , general surgery , finance , economics
At the end of the 20th century several inventors had suggested methods for catheter based implantation of cardiac valves. In September of 2000 Professor Philipp Bonhoeffer made transcatheter valve delivery a reality with the implantation of a stent mounted biological valve in the pulmonary position. Dr. Alain Cribier followed in 2002 with the first successful transcatheter implantation of a valve into the more challenging aortic position. Cardiac surgeons and industry seemed to show little interest in percutaneous valve delivery until January of 2004 when Edwards Life Science invested over $125 million in acquiring PVT, the company building the valves implanted by Dr. Cribier and Medtronic revealed the company’s support for Dr. Bonhoeffer’s efforts. A number of challenges have been identified and significant progress has been made in addressing some of these challenges. This presentation will describe the challenges associated with pulmonic and aortic transcatheter valve delivery. The progress that has been made in overcoming these challenges as well as the efforts being made to overcome the remaining challenges will be discussed.